The Pharmacology Center

Filter Your Results




FDA Approves Portola Pharmaceuticals’ Andexxa for the Reversal of Factor Xa

May 14, 2018 -- Portola Pharmaceuticals, Inc. recently announced that the US Food and Drug Administration (FDA) has approved the company's Andexxa (coagulation factor Xa […

Analysis From ACCELERATE Trial Evaluates ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease

March 12, 2018 -- Steven E. Nissen, MD, presented findings from an analysis of the ACCELERATE trial of ADCY9 genetic variants and cardiovascular outcome with evacetrapib in a …

SMART-DATE Trial Shows Increased Risk of Heart Attack With Short-Term DAPT in ACS Patients

March 12, 2018 -- The SMART-DATE trial was presented by Principal Investigator Hyeon Cheol Gwon, MD, in a Late Breaking Trial session at the American College of Cardiology'…

PHARMCLO Evaluates Genetic Screening to Inform the Selection of Antiplatelet Drugs in ACS Patients

March 11, 2018 -- The PHARMCLO trial demonstrated that patients with acute coronary syndrome (ACS) experienced a substantially lower rate of heart attack, stroke, death from c…

ARTEMIS Investigates If Reducing Copayments Could Improve Adherence to Medication Therapy After Heart Attacks

March 11, 2018 -- Findings from the ARTEMIS study were presented by Tracy Wang, MD, in a Late Breaking Trial session at the American College of Cardiology's (ACC) 67th ann…

Dabigatran Shown to Reduce Major Cardiovascular Complications in Patients With Myocardial Injury After Noncardiac Surgery

March 11, 2018 -- Treatment with the anticoagulant drug dabigatran significantly reduced the risk of death, heart attack, stroke, and other heart or blood vessel complications…

SECURE-PCI Studies Benefit of Administering Statins at Time of PCI

March 11, 2018 -- The SECURE-PCI randomized clinical trial evaluated the effect of administering a loading dose of atorvastatin before planned percutaneous coronary interventi…

Alirocumab PCSK9 Inhibitor Studied in ODYSSEY Outcomes Trial of ACS Patients

March 10, 2018 -- Findings from the ODYSSEY Outcomes trial investigating cardiovascular outcomes with alirocumab after acute coronary syndrome were presented by Philippe Gabri…



US Device Guide

The Cardiac Interventions Today Europe Device Guide offers a searchable, comprehensive listing of the available interventional cardiology devices in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.